D. Anafi

发表

INTRACAVITY ADAPTIVE OPTICS

R. H. Freeman, J. M. Spinhirne, D. Anafi, 1980 .

Intracavity adaptive optics. 2: Tilt correction performance.

R. Freeman, K. Oughstun, J. Spinhirne, 1981, Applied optics.

Intracavity adaptive optics. 1: Astigmatism correction performance.

R. Freeman, H. Garcia, J. Spinhirne, 1981, Applied optics.

Intracavity adaptive optics. 3: Hsuria performance.

R. Freeman, J. Spinhirne, D. Anafi, 1982, Applied optics.

Intracavity adaptive optics. 4: Comparison of theory and experiment.

K. Oughstun, J. Spinhirne, D. Anafi, 1984, Applied optics.

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs.

M. Citron, D. Anafi, L. Narhi, 2000, The Journal of biological chemistry.

Optical mixing in type I and type II KDP with picosecond laser pulses

R. Alfano, D. Anafi, B. Green, 1977 .

Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation*

M. Citron, K. Sitney, D. Anafi, 1999, The Journal of Biological Chemistry.

The native and the heat-induced denatured states of alpha-chymotrypsinogen A: thermodynamic and spectroscopic studies.

J. Völker, K. Breslauer, D. Anafi, 1997, Journal of molecular biology.

Parkinson's Disease-associated α-Synuclein Is More Fibrillogenic than β- and γ-Synuclein and Cannot Cross-seed Its Homologs*

M. Citron, D. Anafi, L. Narhi, 2000, The Journal of Biological Chemistry.

In vitro stoichiometry of complexes between the soluble RANK ligand and the monoclonal antibody denosumab.

John P. Gabrielson, P. Bondarenko, N. Hawkins, 2012, Biochemistry.